3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expression

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          During pregnancy, trophoblast cell invasion needs to be finely controlled. Aberrant trophoblast cell invasion is associated with placental diseases. Epidermal growth factor (EGF) and its receptor, EGFR, are expressed in trophoblast cells. Although the pro-invasive effect of EGF on trophoblast cells has been reported, the underlying mechanism remains largely unknown.

          Results

          In the present study, we conducted an RNA sequencing (RNA-seq) to HTR-8/SVneo human trophoblast cells in response to EGF and identified KISS1 as a target gene of EGF. The human KISS1 gene encodes kisspeptin, also known as metastin, which can suppress tumor metastasis. Our results showed that EGF treatment downregulated KISS1 expression and secretion by activating the EGFR-mediated PI3K/AKT signaling pathway. In addition, the expression of inhibitor of DNA-binding protein 3 (ID3) was downregulated by EGF and that was required for the EGF-suppressed KISS1 expression. Functionally, transwell invasion assays demonstrated that EGF stimulated human trophoblast cell invasion by downregulating KISS1 expression. Preeclampsia (PE) is a placental disease characterized by insufficient trophoblast cell invasion. Our clinical results revealed that serum levels of EGF were downregulated while serum and placental levels of KISS1 were upregulated in PE patients.

          Conclusions

          This study demonstrates that downregulation of EGF can lead to poor trophoblast cell invasion by increasing KISS1 expression which subsequently contributes to the pathogenesis of PE.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12964-021-00783-2.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          DEGseq: an R package for identifying differentially expressed genes from RNA-seq data.

          High-throughput RNA sequencing (RNA-seq) is rapidly emerging as a major quantitative transcriptome profiling platform. Here, we present DEGseq, an R package to identify differentially expressed genes or isoforms for RNA-seq data from different samples. In this package, we integrated three existing methods, and introduced two novel methods based on MA-plot to detect and visualize gene expression difference. The R package and a quick-start vignette is available at http://bioinfo.au.tsinghua.edu.cn/software/degseq
            • Record: found
            • Abstract: found
            • Article: not found

            Pre-eclampsia.

            Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. It is a pregnancy-specific disease characterised by de-novo development of concurrent hypertension and proteinuria, sometimes progressing into a multiorgan cluster of varying clinical features. Poor early placentation is especially associated with early onset disease. Predisposing cardiovascular or metabolic risks for endothelial dysfunction, as part of an exaggerated systemic inflammatory response, might dominate in the origins of late onset pre-eclampsia. Because the multifactorial pathogenesis of different pre-eclampsia phenotypes has not been fully elucidated, prevention and prediction are still not possible, and symptomatic clinical management should be mainly directed to prevent maternal morbidity (eg, eclampsia) and mortality. Expectant management of women with early onset disease to improve perinatal outcome should not preclude timely delivery-the only definitive cure. Pre-eclampsia foretells raised rates of cardiovascular and metabolic disease in later life, which could be reason for subsequent lifestyle education and intervention. Copyright 2010 Elsevier Ltd. All rights reserved.
              • Record: found
              • Abstract: found
              • Article: not found

              ErbB receptors and signaling pathways in cancer.

              The ErbB receptor tyrosine kinases play important roles in normal physiology and in cancer. Epidermal growth factor receptor (EGFR) and ErbB2 in particular are mutated in many epithelial tumors, and clinical studies suggest that they play roles in cancer development and progression. These receptors have been intensely studied, not only to understand the mechanisms underlying their oncogenic potential, but also to exploit them as therapeutic targets. ErbB receptors activate a multiplicity of intracellular pathways via their ability to interact with numerous signal transducers. Furthermore, there are now many ErbB-targeted inhibitors used in the clinic. In this review we will concentrate on breast tumors with ERBB2 gene amplification/receptor overexpression and non-small cell lung cancer (NSCLC) with activating EGFR mutations. We will discuss data showing the important role that the PI3K/Akt pathway plays, not only in cancer development, but also in response to targeted therapies. Finally, mechanisms contributing to resistance to ErbB-targeted therapeutics will also be discussed.

                Author and article information

                Contributors
                fanglly@163.com
                15638582721@163.com
                w2495687480@163.com
                liyuxi123321@163.com
                yanyangzzu@foxmail.com
                wuze1210@163.com
                jungchien.cheng@gmail.com
                syp2008@vip.sina.com
                Journal
                Cell Commun Signal
                Cell Commun Signal
                Cell Communication and Signaling : CCS
                BioMed Central (London )
                1478-811X
                7 October 2021
                7 October 2021
                2021
                : 19
                : 101
                Affiliations
                GRID grid.412633.1, Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, , The First Affiliated Hospital of Zhengzhou University, ; 40, Daxue Road, Zhengzhou, 450052 Henan China
                Author information
                http://orcid.org/0000-0002-5399-9327
                Article
                783
                10.1186/s12964-021-00783-2
                8499481
                34620174
                e9236796-7bff-4348-a7f4-b039c80ec2f8
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 16 July 2021
                : 30 August 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, national natural science foundation of china;
                Award ID: 32070848
                Award ID: 32050410302
                Award ID: 2019YFA 0110900
                Award ID: 81820108016
                Award Recipient :
                Funded by: key r&d program of henan province
                Award ID: 202102310062
                Award Recipient :
                Funded by: henan province medical science and technique r&d program
                Award ID: SBGJ202002052
                Award ID: SBGJ202002046
                Award Recipient :
                Funded by: special fund for young teachers from the zhengzhou university
                Award ID: JC202054006
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2021

                Cell biology
                egf,kiss1,id3,trophoblast invasion,preeclampsia
                Cell biology
                egf, kiss1, id3, trophoblast invasion, preeclampsia

                Comments

                Comment on this article

                Related Documents Log